130 related articles for article (PubMed ID: 16481733)
1. Combining chemotherapy with virotherapy: a novel treatment strategy for malignant pleural mesothelioma.
Curiel DT; Zhu ZB
Cancer Biol Ther; 2006 Feb; 5(2):236-7. PubMed ID: 16481733
[No Abstract] [Full Text] [Related]
2. A catalogue of treatment and technologies for malignant pleural mesothelioma.
Schunselaar LM; Quispel-Janssen JM; Neefjes JJ; Baas P
Expert Rev Anticancer Ther; 2016; 16(4):455-63. PubMed ID: 26943000
[TBL] [Abstract][Full Text] [Related]
3. ["Crossing Jordan"--pleural mesothelioma evolving as a treatable disease].
Eberhardt W
Pneumologie; 2004 Apr; 58(4):208-9. PubMed ID: 15098156
[No Abstract] [Full Text] [Related]
4. Hyperthermia: has its time come?
Smythe WR; Mansfield PF
Ann Surg Oncol; 2003 Apr; 10(3):210-2. PubMed ID: 12679303
[No Abstract] [Full Text] [Related]
5. What's the place of immunotherapy in malignant mesothelioma treatments?
Grégoire M
Cell Adh Migr; 2010; 4(1):153-61. PubMed ID: 20179421
[TBL] [Abstract][Full Text] [Related]
6. The issue of studies evaluating biomarkers which predict outcome after pemetrexed-based chemotherapy in malignant pleural mesothelioma.
Mairinger F; Vollbrecht C; Mairinger T; Popper H
J Thorac Oncol; 2013 Aug; 8(8):e80-2. PubMed ID: 23857409
[No Abstract] [Full Text] [Related]
7. Radiation-induced cellular DNA damage repair response enhances viral gene therapy efficacy in the treatment of malignant pleural mesothelioma.
Adusumilli PS; Chan MK; Hezel M; Yu Z; Stiles BM; Chou TC; Rusch VW; Fong Y
Ann Surg Oncol; 2007 Jan; 14(1):258-69. PubMed ID: 17080237
[TBL] [Abstract][Full Text] [Related]
8. Complete response and long-term survival in malignant pleural mesothelioma: case report.
Takanen S; Resuli B; Graziano V; Parisi A; Lisi R; Raffetto N; Tombolini V
Anticancer Res; 2012 Apr; 32(4):1485-7. PubMed ID: 22493390
[TBL] [Abstract][Full Text] [Related]
9. Innovative therapies for malignant pleural mesothelioma.
Roberts JR
Chest; 1997 Oct; 112(4 Suppl):269S-271S. PubMed ID: 9337302
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant chemotherapy in malignant pleural mesothelioma.
Stahel R; Weder W
Lung Cancer; 2005 Jul; 49 Suppl 1():S69-70. PubMed ID: 15950804
[No Abstract] [Full Text] [Related]
11. A novel translational approach for human malignant pleural mesothelioma: heparanase-assisted dual virotherapy.
Watanabe Y; Kojima T; Kagawa S; Uno F; Hashimoto Y; Kyo S; Mizuguchi H; Tanaka N; Kawamura H; Ichimaru D; Urata Y; Fujiwara T
Oncogene; 2010 Feb; 29(8):1145-54. PubMed ID: 19935710
[TBL] [Abstract][Full Text] [Related]
12. Multimodality therapy in mesothelioma: role of chemotherapy.
Vogelzang NJ
Thorac Surg Clin; 2004 Nov; 14(4):531-42. PubMed ID: 15559060
[TBL] [Abstract][Full Text] [Related]
13. Management of recurrence after initial surgery for malignant pleural mesothelioma: a mini-review.
Halezeroğlu S; Migliore M
Future Oncol; 2015; 11(24 Suppl):23-7. PubMed ID: 26638919
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of malignant pleural mesothelioma--present status and future view].
Yano T; Morodomi Y; Ito K; Miura N; Takenaka T; Kawano D; Shoji F; Maehara Y
Fukuoka Igaku Zasshi; 2008 Apr; 99(4):74-9. PubMed ID: 18646592
[No Abstract] [Full Text] [Related]
15. Ifosfamide, carboplatin and etoposide combined with 41.8 degrees C whole body hyperthermia for malignant pleural mesothelioma.
Bakhshandeh A; Bruns I; Traynor A; Robins HI; Eberhardt K; Demedts A; Kaukel E; Koschel G; Gatzemeier U; Kohlmann T; Dalhoff K; Ehlers EM; Gruber Y; Zumschlinge R; Hegewisch-Becker S; Peters SO; Wiedemann GJ
Lung Cancer; 2003 Mar; 39(3):339-45. PubMed ID: 12609573
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin-induced GADD34 upregulation potentiates oncolytic viral therapy in the treatment of malignant pleural mesothelioma.
Adusumilli PS; Chan MK; Chun YS; Hezel M; Chou TC; Rusch VW; Fong Y
Cancer Biol Ther; 2006 Jan; 5(1):48-53. PubMed ID: 16294031
[TBL] [Abstract][Full Text] [Related]
17. Pleurectomy/decortication plus chemotherapy: outcomes of 40 cases of malignant pleural mesothelioma.
Colaut F; Toniolo L; Vicario G; Scapinello A; Visentin C; Manente P; Sartori CA
Chir Ital; 2004; 56(6):781-6. PubMed ID: 15771030
[TBL] [Abstract][Full Text] [Related]
18. Malignant pleural mesothelioma.
Ceresoli GL; Betta GP; Castagneto B; Facciolo F; Arcangeli G; Zucali PA; Libener R; De Giovanni D; Melis E; Mirri MA
Ann Oncol; 2006 Mar; 17 Suppl 2():ii13-16. PubMed ID: 16608972
[No Abstract] [Full Text] [Related]
19. A phase II study of intrapleural immunochemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy, and long-term subcutaneous IL-2 in stage II-III malignant pleural mesothelioma.
Rusch VW
Eur J Cardiothorac Surg; 2007 Mar; 31(3):534-5. PubMed ID: 17267238
[No Abstract] [Full Text] [Related]
20. Multimodal treatment for malignant pleural mesothelioma.
Rintoul RC; Treasure T; Macbeth F
Lancet Oncol; 2015 Dec; 16(16):1576-7. PubMed ID: 26538424
[No Abstract] [Full Text] [Related]
[Next] [New Search]
